fingolimod hydrochloride has been researched along with pexidartinib in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (pexidartinib) | Trials (pexidartinib) | Recent Studies (post-2010) (pexidartinib) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 143 | 9 | 141 |
| Protein | Taxonomy | fingolimod hydrochloride (IC50) | pexidartinib (IC50) |
|---|---|---|---|
| Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | 0.0136 | |
| Macrophage colony-stimulating factor 1 receptor | Mus musculus (house mouse) | 0.014 | |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | 0.036 | |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.027 | |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | 0.0096 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 1.5 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.027 | |
| Aurora kinase B | Homo sapiens (human) | 0.643 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ducruet, AF; Lawton, MT; Qiu, S; Sheth, KN; Shi, E; Shi, K | 1 |
1 other study(ies) available for fingolimod hydrochloride and pexidartinib
| Article | Year |
|---|---|
Chronic inflammation, cognitive impairment, and distal brain region alteration following intracerebral hemorrhage.
Topics: Aminopyridines; Animals; Brain; Cerebral Hemorrhage; Cognition; Cognitive Dysfunction; Disease Models, Animal; Fingolimod Hydrochloride; Flow Cytometry; Hippocampus; Inflammation; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroimaging; Neuronal Plasticity; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2019 |